M. Diana Brainard's Insider Trades & SAST Disclosures
M. Diana Brainard's most recent trade in Nektar Therapeutics was a trade of 120,000 Stock Option done . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M. Diana Brainard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nektar Therapeutics | Diana M. Brainard | Director | 31 Dec 2024 | 120,000 | 120,000 | - | - | Stock Option | ||
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 19 Nov 2024 | 8,706 | 723,363 | - | 0.5 | 4,775 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.86 per share. | 05 Nov 2024 | 10,609 | 732,069 | - | 0.9 | 9,176 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 21 Oct 2024 | 9,752 | 742,678 | - | 0.8 | 7,597 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 03 Oct 2024 | 1,493 | 752,430 | - | 0.8 | 1,216 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.74 per share. | 20 Aug 2024 | 5,390 | 753,923 | - | 0.7 | 3,996 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.76 per share. | 19 Aug 2024 | 3,091 | 759,313 | - | 0.8 | 2,348 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 05 Aug 2024 | 10,847 | 762,404 | - | 0.7 | 7,970 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 19 Jul 2024 | 9,731 | 773,251 | - | 0.8 | 7,299 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 02 Jul 2024 | 1,489 | 782,982 | - | 0.7 | 1,072 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 21 May 2024 | 5,149 | 784,471 | - | 0.8 | 4,080 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 17 May 2024 | 3,075 | 789,620 | - | 0.7 | 2,304 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 03 May 2024 | 10,240 | 792,695 | - | 0.8 | 8,151 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 19 Apr 2024 | 9,601 | 802,935 | - | 0.8 | 7,207 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.77 per share. | 02 Apr 2024 | 1,533 | 812,536 | - | 0.8 | 1,183 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.71 per share. | 20 Feb 2024 | 5,155 | 814,069 | - | 0.7 | 3,650 | Common Stock |
| Kalaris Therapeutics Inc. | Brainard M. Diana | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.70 per share. | 20 Feb 2024 | 3,097 | 819,224 | - | 0.7 | 2,153 | Common Stock |
| Kalaris Therapeutics Inc. | Diana Brainard M. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 05 Feb 2024 | 41,421 | 822,321 | - | 0.7 | 27,752 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 23 Jan 2024 | 9,500 | 863,742 | - | 0.7 | 6,369 | Common Stock |
| Kalaris Therapeutics Inc. | M. Diana Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 04 Jan 2024 | 1,664 | 873,242 | - | 0.6 | 1,063 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 17 Aug 2023 | 11,361 | 895,938 | - | 2.5 | 28,351 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.79 per share. | 17 Aug 2023 | 4,055 | 891,883 | - | 2.8 | 11,313 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 19 Jul 2023 | 8,342 | 907,299 | - | 3.6 | 29,710 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.05 per share. | 05 Jul 2023 | 5,275 | 915,641 | - | 3.0 | 16,063 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.21 per share. | 18 May 2023 | 4,536 | 916,628 | - | 4.2 | 19,115 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 19 Apr 2023 | 8,408 | 921,164 | - | 3.7 | 31,183 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 21 Feb 2023 | 5,122 | 929,572 | - | 6.6 | 33,935 | Common Stock |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 617,500 | 1,836,875 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 332,500 | 934,964 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Diana M. Brainard | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 19 Jan 2023 | 34,435 | 601,607 | - | 5.1 | 174,851 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges